Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash $ 24,142 $ 88,033
Accounts receivable, net 111,966 0
Grant receivable 153,360 0
Related party receivable 100,000 0
Inventory 133,597 0
Prepaid expenses 42,731 29,963
Total current assets 565,796 117,996
Property and equipment, net 15,213 18,977
Right to use assets 189,468 199,184
Other assets:    
Intangible assets, net 3,148,269 7,848
Goodwill 2,840,400 0
Deposits, long term 41,936 41,936
Total other assets 6,030,605 49,784
Total assets 6,801,082 385,941
Current liabilities:    
Accounts payable and accrued expenses, including related party payables of $1,487,469 and $1,349,465, respectively 10,862,632 5,574,831
Deferred revenue, grant 56,590 56,590
Lease liability, short term 40,863 40,057
Notes payable, net of debt discount of $4,540 and $41,452, respectively 1,490,190 1,343,278
Notes payable, related parties, net of debt discount of $0 and $0, respectively 993,959 1,192,859
Total current liabilities 13,444,234 8,207,615
Long term liabilities:    
Economic Injury Disaster loan, long term 70,661 71,029
Upfront purchase price liability 329,492 0
Royalty liability 190,929 0
Royalty obligation, net of discount of $4,303,364 and $4,418,698, related parties 4,418,736 4,303,402
Lease liability, long term 148,605 159,127
Total liabilities 18,602,657 12,741,173
Deficit:    
Common stock, $0.001 par value; 750,000,000 shares authorized, 16,897,984 and 13,299,349 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 16,898 13,299
Common stock subscribed 100,000 100,000
Additional paid in capital 72,355,629 70,953,807
Accumulated deficit (84,050,549) (83,209,142)
Total deficit attributable to BioCorRx Inc. (11,556,406) (12,120,420)
Non-controlling interest (245,169) (234,812)
Total deficit (11,801,575) (12,355,232)
Total liabilities and deficit 6,801,082 385,941
Series A Convertible Preferred Stock [Member]    
Deficit:    
Preferred Stock, Value 16,000 16,000
Series B Convertible Preferred Stock [Member]    
Deficit:    
Preferred Stock, Value $ 5,616 $ 5,616